Waverley Pharma (TSXV:WAVE) Market Cap : C$1.35 Mil (As of May. 02, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Waverley Pharma Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Waverley Pharma's share price for the quarter that ended in Sep. 2023 was C$0.025. Waverley Pharma's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 54.00 Mil. Therefore, Waverley Pharma's market cap for the quarter that ended in Sep. 2023 was C$1.35 Mil.

Waverley Pharma's quarterly market cap declined from Mar. 2023 (C$2.70 Mil) to Jun. 2023 (C$2.16 Mil) and declined from Jun. 2023 (C$2.16 Mil) to Sep. 2023 (C$1.35 Mil).

Waverley Pharma's annual market cap declined from Dec. 2020 (C$6.75 Mil) to Dec. 2021 (C$4.32 Mil) and declined from Dec. 2021 (C$4.32 Mil) to Dec. 2022 (C$1.62 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Waverley Pharma's Enterprise Value for Today is C$2.46 Mil.

Waverley Pharma Market Cap Historical Data

The historical data trend for Waverley Pharma's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waverley Pharma Market Cap Chart

Waverley Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Market Cap

Get a 7-Day Free Trial

15.12

5.40

6.75

4.32

1.62

Waverley Pharma Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Market Cap	Get a 7-Day Free Trial															3.24	1.62	2.70	2.16	1.35

Competitive Comparison of Waverley Pharma's Market Cap

For the Biotechnology subindustry, Waverley Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Waverley Pharma's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Waverley Pharma's Market Cap distribution charts can be found below:

* The bar in red indicates where Waverley Pharma's Market Cap falls into.

Waverley Pharma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Waverley Pharma's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )	=	Share Price (A: Dec. 2022 )	*	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	C$0.03	*	54
	=	C$1.62

Waverley Pharma's Market Cap for the quarter that ended in Sep. 2023 is calculated as

Market Cap (Q: Sep. 2023 )	=	Share Price (Q: Sep. 2023 )	*	Shares Outstanding (EOP) (Q: Sep. 2023 )
	=	C$0.025	*	54
	=	C$1.35

Waverley Pharma (TSXV:WAVE) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Waverley Pharma Market Cap Related Terms

Thank you for viewing the detailed overview of Waverley Pharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Waverley Pharma (TSXV:WAVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Waverley Pharma Inc (TSXV:WAVE) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

5GZ:Germany

Address

1250 Waverley Street, Suite 4, Winnipeg, MB, CAN, R3T 6C6

Website

https://www.waverleypharma.com

Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Capecitabine and Temozolomide, among others.